NasdaqCM - Nasdaq Real Time Price USD

GT Biopharma, Inc. (GTBP)

2.8900
+0.2200
+(8.24%)
At close: May 23 at 4:00:00 PM EDT
2.8800
-0.01
(-0.35%)
After hours: May 23 at 7:28:50 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
13,205
14,364
13,576
21,257
57,515
Operating Income
-13,205
-14,364
-13,576
-21,257
-57,515
Net Non Operating Interest Income Expense
292
402
567
284
-680
Other Income Expense
1,241
800
5,412
89
182
Pretax Income
-11,672
-13,162
-7,597
-20,884
-58,013
Tax Provision
0
--
--
--
--
Net Income Common Stockholders
-11,672
-13,162
-7,597
-20,884
-58,013
Diluted NI Available to Com Stockholders
-11,672
-13,162
-7,597
-20,884
-58,013
Basic EPS
-5.63
--
-5.64
-19.46
-61.80
Diluted EPS
-5.63
--
-5.64
-19.46
-61.80
Basic Average Shares
2,138.4880
--
1,347.7130
1,072.9960
938.5200
Diluted Average Shares
2,138.4880
--
1,347.7130
1,072.9960
938.5200
Total Operating Income as Reported
-13,205
-14,364
-13,576
-21,257
-57,515
Total Expenses
13,205
14,364
13,576
21,257
57,515
Net Income from Continuing & Discontinued Operation
-11,672
-13,162
-7,597
-20,884
-58,013
Normalized Income
-12,940
-13,962
-12,989
-20,973
-58,195
Interest Income
292
402
780
292
38
Interest Expense
22
0
213
8
718
Net Interest Income
292
402
567
284
-680
EBIT
-12,003
-13,162
-7,384
-20,876
-57,295
EBITDA
-12,003
-13,162
-7,384
-20,876
-57,295
Reconciled Depreciation
12
--
--
--
--
Net Income from Continuing Operation Net Minority Interest
-11,672
-13,162
-7,597
-20,884
-58,013
Total Unusual Items Excluding Goodwill
1,268
800
5,392
89
182
Total Unusual Items
1,268
800
5,392
89
182
Normalized EBITDA
-13,271
-13,962
-12,776
-20,965
-57,477
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/27/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NNVC NanoViricides, Inc.
1.7900
+20.95%
 
NRXP NRx Pharmaceuticals, Inc.
2.6200
-2.60%
 
VTGN Vistagen Therapeutics, Inc.
2.4100
-0.82%
 
ABP Abpro Corporation
0.2120
-7.83%
 
KTTA Pasithea Therapeutics Corp.
0.9153
-2.73%
 
BCLI Brainstorm Cell Therapeutics Inc.
1.0800
-2.70%
 
BDRX Biodexa Pharmaceuticals Plc
1.1500
-17.27%
 
NCNA NuCana plc
0.0380
-3.55%
 
PLRZ Polyrizon Ltd.
0.0034
-19.05%
 
ARMP Armata Pharmaceuticals, Inc.
1.8900
+1.07%